Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Cao

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Journal of the American College of Cardiology|July 5, 2023
P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsFelice Gragnano, Davide Cao, Leah Pirondini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
The Annals of Thoracic Surgery|October 19, 2023
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art ReviewMario Gaudino, Antonino Di Franco, Eloisa Arbustini, et al.
JACC. Cardiovascular Interventions|September 10, 2021
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent ImplantationRoxana Mehran, Davide Cao, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|October 19, 2023
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art ReviewMario Gaudino, Antonino Di Franco, Eloisa Arbustini, et al.
Lancet (London, England)|January 11, 2026
Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trialAlexandre Abizaid, Roxana Mehran, Angelo Oliva, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trialUsman Baber, Davide Cao, Timothy Collier, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
JACC. Cardiovascular Interventions|July 9, 2021
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCIDominick J Angiolillo, Davide Cao, Usman Baber, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|July 5, 2023
P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsFelice Gragnano, Davide Cao, Leah Pirondini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
The Annals of Thoracic Surgery|October 19, 2023
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art ReviewMario Gaudino, Antonino Di Franco, Eloisa Arbustini, et al.
JACC. Cardiovascular Interventions|September 10, 2021
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent ImplantationRoxana Mehran, Davide Cao, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|October 19, 2023
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art ReviewMario Gaudino, Antonino Di Franco, Eloisa Arbustini, et al.
Lancet (London, England)|January 11, 2026
Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trialAlexandre Abizaid, Roxana Mehran, Angelo Oliva, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trialUsman Baber, Davide Cao, Timothy Collier, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
JACC. Cardiovascular Interventions|July 9, 2021
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCIDominick J Angiolillo, Davide Cao, Usman Baber, et al.
Pageof 15